These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 37286711)

  • 21. Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints.
    Wang X; Chen D; Shi Y; Luo J; Zhang Y; Yuan X; Zhang C; Shu H; Yu W; Tian J
    Front Immunol; 2023; 14():1123231. PubMed ID: 37153542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and development of a novel risk model based on cuproptosis-associated RNA methylation regulators for predicting prognosis and characterizing immune status in hepatocellular carcinoma.
    Li D; Shi Z; Liu X; Jin S; Chen P; Zhang Y; Chen G; Fan X; Yang J; Lin H
    Hepatol Int; 2023 Feb; 17(1):112-130. PubMed ID: 36598701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cuproptosis-associated genes (CAGs) contribute to the prognosis prediction and potential therapeutic targets in hepatocellular carcinoma.
    Shi X; Shi D; Yin Y; Wu Y; Chen W; Yu Y; Wang X
    Cell Signal; 2024 May; 117():111072. PubMed ID: 38307306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of cuproptosis-related gene DLAT in various cancers: a bioinformatic analysis and preliminary verification on pro-survival autophagy.
    Yang Q; Zeng S; Liu W
    PeerJ; 2023; 11():e15019. PubMed ID: 36949759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cuproptosis-Related LncRNA Signature for Predicting Prognosis of Hepatocellular Carcinoma: A Comprehensive Analysis.
    Chen Q; Sun T; Wang G; Zhang M; Zhu Y; Shi X; Ding Z
    Dis Markers; 2022; 2022():3265212. PubMed ID: 36452343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cuproptosis enhances docetaxel chemosensitivity by inhibiting autophagy via the DLAT/mTOR pathway in prostate cancer.
    Wen H; Qu C; Wang Z; Gao H; Liu W; Wang H; Sun H; Gu J; Yang Z; Wang X
    FASEB J; 2023 Sep; 37(9):e23145. PubMed ID: 37584654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct cuproptosis patterns in hepatocellular carcinoma patients correlate with unique immune microenvironment characteristics and cell-cell communication, contributing to varied overall survival outcomes.
    Wang Y; Mang X; Guo X; Pu J
    Front Immunol; 2024; 15():1379690. PubMed ID: 38868777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC.
    Qin H; Sheng W; Zhang G; Yang Q; Yao S; Yue Y; Zhang P; Zhu Y; Wang Q; Chen Y; Zeng H; Weng J; Yu F; Yang J
    Front Genet; 2023; 14():1094793. PubMed ID: 36891150
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma.
    Li J; Yin J; Li W; Wang H; Ni B
    Cancer Cell Int; 2023 Jan; 23(1):7. PubMed ID: 36647100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the cuproptosis-related molecular subtypes and an immunotherapy prognostic model in hepatocellular carcinoma.
    Zhang L; Xu J; Chu X; Zhang H; Yao X; Zhang J; Guo Y
    BMC Bioinformatics; 2022 Nov; 23(1):485. PubMed ID: 36384423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer.
    Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M
    BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cuproptosis regulator-mediated patterns associated with immune infiltration features and construction of cuproptosis-related signatures to guide immunotherapy.
    Wang G; Xiao R; Zhao S; Sun L; Guo J; Li W; Zhang Y; Bian X; Qiu W; Wang S
    Front Immunol; 2022; 13():945516. PubMed ID: 36248857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of hub cuproptosis related genes and immune cell infiltration characteristics in periodontitis.
    Liu S; Ge J; Chu Y; Cai S; Wu J; Gong A; Zhang J
    Front Immunol; 2023; 14():1164667. PubMed ID: 37215133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of prognosis, immune infiltration, and personalized treatment of hepatocellular carcinoma by analysis of cuproptosis-related long noncoding RNAs and verification
    Li S; Zhu Z; Lu J; Cao W; Song F; Xiao C; Zhang P; He Z; Weng J; Xu J
    Front Oncol; 2023; 13():1159126. PubMed ID: 37746284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of cuproptosis identified immune microenvironment and prognosis in acute myeloid leukemia.
    Luo D; Liu S; Luo J; Chen H; He Z; Gao Z; Wen Z; Liu X; Xu N
    Clin Transl Oncol; 2023 Aug; 25(8):2393-2407. PubMed ID: 36826709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cuproptosis-related gene
    Huang S; Cai C; Zhou K; Wang X; Wang X; Cen D; Weng G
    Aging (Albany NY); 2023 Nov; 15(21):12314-12329. PubMed ID: 37938155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cuproptosis-related signature for clinical prognosis and immunotherapy sensitivity in hepatocellular carcinoma.
    Xu S; Dong K; Gao R; Yang Y; Zhou Y; Luo C; Chen W; Liu SM
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12249-12263. PubMed ID: 37434092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Copper metabolism-related risk score identifies hepatocellular carcinoma subtypes and SLC27A5 as a potential regulator of cuproptosis.
    Li X; Wang J; Guo Z; Ma Y; Xu D; Fan D; Dai P; Chen Y; Liu Q; Jiao J; Fan J; Wu N; Li X; Li G
    Aging (Albany NY); 2023 Dec; 15(24):15084-15113. PubMed ID: 38157255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and validation of a novel cuproptosis-related genes signature associated with prognosis, clinical implications and immunotherapy of hepatocellular carcinoma.
    He F; Zeng P; Ma S; Yang X; Liu H; Liu Q; Zhou Y; Zhu H
    Front Pharmacol; 2023; 14():1088993. PubMed ID: 36843949
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.